Outcome of Intravenous Thrombolysis for Stroke Patients in the 3-4.5 Hour Time Window
Status:
Unknown status
Trial end date:
2014-12-01
Target enrollment:
Participant gender:
Summary
The time window for intravenous recombinant tissue plasminogen activator treatment in
ischemic stroke patients has been extended to 4.5h. Little is known about intravenous
recombinant tissue plasminogen activator use in the 3-4.5 hour time window among Chinese
stroke patients. This exploratory study was to describe the feasibility and outcome of
treatment with intravenous recombinant tissue plasminogen activator in the expanded time
window, and to offer suggestions for future clinical work in China.
Details
Lead Sponsor:
Wuhan General Hospital of Guangzhou Military Command